TARDBP and Alzheimer disease: Foulds et al. developed an ELISA-based method to assess the levels of phosphorylated TDP-43 (pTDP-43) within plasma samples, which seemed to be more reliable than total TDP-43 in distinguishing FTD-TDP from other forms of FTD or Alzheimer's disease (5).